News for Moberg Pharma AB (publ) (MB8A.F)

Published at

Feb 9, 2021 5:23 AM

by globalbankingandfinance.com

positive

positive

The Top Five Players Hold Around 43.9% of the Global Onychomycosis Treatment Market

According to a new market study by Future Market Insights (FMI), the global onychomycosis treatment market will expand at a healthy rate between 2018 and 2028.

NVSN.MX NVSEF NVS NOVN.SW NOTA.MU NOTA.F NOTA.BE MB8A.F CIPLA.NS CIPLA.BO BFRA BAYZF BAYRY BAYNN.MX BAYN.F BAYN.DE BAYN.BE BAYER.BD BAYA.MU BAYA.F BAYA.DE BAYA.BE BAY.MI B8FE.SG B8F.F B8F.DE

Read more →
Published at

Feb 2, 2021 8:08 AM

by marketscreener.com

positive

positive

Moberg Pharma : Year-end report for the financial year 2020 to be published on February 9 - Invitation to teleconference

The teleconference will be hosted by Moberg Pharmas's CEO Anna Ljung and VP Finance Mark Beveridge. The presentation will be held in English. Date: ... | February 2, 2021

MB8A.F

Read more →
Published at

Jan 29, 2021 8:37 AM

by prnewswire.com

positive

positive

New number of shares and votes in Moberg Pharma AB (publ)

/PRNewswire/ -- During January 2021, the registered number of shares and votes in Moberg Pharma AB (OMX: MOB) ("Moberg Pharma" or the "Company") has increased...

MB8A.F

Read more →